CWM
CLB icon

Chesapeake Wealth Management’s Core Laboratories CLB Stock Holding History

Chesapeake Wealth Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,964
Closed -$227K – 185
2018
Q3 		$227K Sell
1,964
-1,837
-48% -$207K 0.1% 173
2018
Q2 		$479K Buy
3,801
+1,576
+71% +$192K 0.22% 107
2018
Q1 		$241K Buy
+2,225
New +$246K 0.11% 162

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Chesapeake Wealth Management's CLB Position: Q4 2018 in Review

Chesapeake Wealth Management sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 1,964 shares — an estimated $227K sold.

Chesapeake Wealth Management first reported a position in CLB in Q1 2018 and held it in 3 quarters. The position peaked at $479K in Q2 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Chesapeake Wealth Management reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Chesapeake Wealth Management sold 1,964 Core Laboratories shares in Q4 2018, an estimated $227K.
  • Chesapeake Wealth Management first reported a position in Core Laboratories in Q1 2018 and held it in 3 quarters.
  • Chesapeake Wealth Management's Core Laboratories position peaked at $479K in Q2 2018.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Chesapeake Wealth Management's 13F filing for Q4 2018, filed 6 Feb 2019.